-
-
-
-
-
-
-
Red Light Holland's Wholly Owned Subsidiary, Filament Health, Expands Distribution of PEX010 Across Canadian and U.S. Research Institutions
-
-
-
-
-
-
-
Red Light Holland Highlights U.S. FDA-Authorized Study Supporting Multi-Session Psilocybin Therapy using Filament Health's Patented PEX010 Botanical Drug Candidate
-
-
-
-
-
-
-
Red Light Holland to acquire Filament Health in all-share deal
-
-
-
-
-
-
-
Red Light Holland Submits Permit Application to the Township of Cavan-Monaghan for the Company's 65,000 Square Foot Mushroom Farm
-
-
-
-
-
-
1,157,770 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

